NCCN Guidelines® Insights - Acute Myeloid Leukemia, Version 2.2013
These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia (AML) and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, feature recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and provide guidance on maintenance strategies for APL.
This activity has been designated to meet the educational needs of physicians, nurses, and pharmacists involved in the management of patients with cancer.
Upon completion of this activity, participants will be able to:
- Integrate into professional practice the updates to NCCN Guidelines for AML
- Describe the rationale behind the decision-making process for developing the NCCN Guidelines for AML
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician